Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
Healthcare
$27.69 +1.77%
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
52W Low $24.15High $32.23
Volume 0.40M
Average 0.51M
AVLN Total Current Liabilities
All obligations due within one year.
No reported Total Current Liabilities figures are available to summarize.
Total Current Liabilities history
Currency unavailable · from the balance sheet
No Total Current Liabilities data reported for this period type.
Total Current Liabilities vs competitors
How AVLN compares with its peers on the latest reported figures
AVLN Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $438.74M USD | +40.8% | +35.1% | 20.9% | |
| Mar 2026 | $134.56M USD | +16.1% | +36.5% | 18.1% | |
| Mar 2026 | $19.79M USD | +4.2% | +14.3% | 12.2% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 7.53M SEK | — | — | 7.9% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +16.1% | +35.1% | 15.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.